Merck, an American pharmaceutical company, has partnered with North Carolina A&T State University, the country’s largest HBCU, to establish the Merck Biotechnology Learning Center.
Through collaboration with Merck’s two North Carolina-based manufacturing plants in Durhman and Wilson, the new facility will provide NCAT students with advanced academic opportunities in biotechnology through expanded classroom and laboratory spaces, as well as access to state-of-the-art biopharmaceutical manufacturing equipment. Students will also be exposed to potential employment opportunities with Merck. Additionally, leaders from Merck will utilize the new Biotechnology Learning Center to train new and existing employees on vaccine manufacturing.
“This collaboration signifies a union between academia and industry, and a commitment to excellence, innovation and the advancement of scientific knowledge,” said Tonya Smith-Jackson, provost and executive vice chancellor of academic affairs for North Carolina A&T State University.
